Report

src

Global MRI-Guided Neurosurgical Ablation Market by Types (RF Ablation Systems, Laser Ablation Systems, Focused Ultrasound Systems, Accessories) and by End-Users/Application (Hospitals, Clinics, and Ambulatory Surgical Centers) Global Market Share, Forecast Data, In-Depth Analysis, and Detailed Overview, and Forecast, 2015 - 2027

 Report Code
 Category
 Published Date
 Pages
 Format
MNR-1419
Healthcare
12 October 2020
201
PDF
Customization
  • We provide customized solutions to cater to your specific requirement services any region, product, or any specific market segment.

The report on the global MRI-guided neurosurgical ablation market analyzes complete scenario i.e., existing as well as future visions of MRI-guided neurosurgical ablation market. It includes detailed overview of MRI-guided neurosurgical ablation market along with market pictures. Additionally, report has included complete data of the various segments in the global MRI-guided neurosurgical ablation market followed by its End-Users, end users and region wide segmentation. Moreover, report has highlights of global key players present in this market. Top global players are analyzed completely along with their financials, technological innovations, key developments, apart from future strategies, SWOT analysis, acquisitions & mergers, and market footprint.

Global MRI-guided neurosurgical ablation market report offers in-depth insights, revenue details, and other vital information regarding the global MRI-guided neurosurgical ablation market, and the various trends, drivers, restraints, opportunities, and threats in the target market till year 2026. Hence, it covers the impact of these drivers and restraints on demand for this market during the forecast period. The report also includes PEST analysis, Porter’s Five Forces analysis, and opportunity map analysis for in-depth understanding of the market.

It provides historical data along with future forecast as well as detailed analysis of market on a global, regional and country level. Important market data of this market is projected in the form of form of tables, graphics, and pictures. On a regional basis, the market is categorized into five regions that include North America, Europe, Asia Pacific, Latin America, and Middle & East Africa. It analyzes complete scenario of each and every region along with highest share holder of MRI-guided neurosurgical ablation market.

Market Segmentation:
Segmentation by Type RF Ablation Systems
Laser Ablation Systems
Focused Ultrasound Systems
Accessories
Segmentation by Application Hospitals
Clinics
Ambulatory Surgical Centers
Market, By Regions North America (the United States, Canada, and Mexico)
Europe (Germany, UK, France, Italy, and Russia, etc.)
Asia-Pacific (China, Japan, ASEAN, India, and Korea)
The Middle East and Africa (UAE, Egypt, South Africa, Saudi Arabia)
South America (Brazil, Chile, Peru, and Argentina)

In addition, MRI-guided neurosurgical ablation market report sorted and categorized the information and data according to the major geographical regions which are expected to impact on the industry in forecast period.

Report also provides factors that are contributing to and influencing the expansion of the global MRI-guided neurosurgical ablation market. It projects the market assessment for the predicted time. Along with all these report includes the manufacturing process along with shipment, price, revenue, gross profit, potential, interview records, business distribution, etc. This enables users to get complete scenario of competitive analysis of the market.

Pivotal Fundamentals of the Global MRI-Guided Neurosurgical Ablation Market Report:
  • Holistic in-depth detailed analysis, regarding the parent market.
  • Detailed information about the current R&D activities performed by each MRI-guided neurosurgical ablation market player.
  • Region-wise and country-wise breakdown of the MRI-guided neurosurgical ablation market to get the revenue, and growth lookout in these areas.
  • Key factors which are influencing the consumption pattern of consumers across various regions and countries.
  • Historical and future progress of the global MRI-guided neurosurgical ablation market.
  • Year-on-year growth of the global MRI-guided neurosurgical ablation market in terms of value and volume.
Conclusion:
At last report covers a short outline of the dealers, distributors, and suppliers. Additionally, it provides sales channel, analysis findings and results. It spots some new entrants within the market. The study thus, suggests a brand new proposition to embellish MRI-guided neurosurgical ablation market and nurture business as it explains current global market as well as future market.

Chapter 1 MRI-Guided Neurosurgical Ablation Overview
1.1 Product Overview and Scope of MRI-Guided Neurosurgical Ablation

Chapter 2 Impact of COVID 19
2.1 Impact on Healthcare Industry
2.2 Impact on MRI-Guided Neurosurgical Ablation
2.3 Consumer Buying Behavior based on MRI-Guided Neurosurgical Ablation
2.4 Recovery and forecast Analysis based on MRI-Guided Neurosurgical Ablation

Chapter 3 Executive Summary 
3.1 Drivers for MRI-Guided Neurosurgical Ablation: 
3.2 Restrain for MRI-Guided Neurosurgical Ablation:
3.3 Opportunity for MRI-Guided Neurosurgical Ablation: 
3.4 Global MRI-Guided Neurosurgical Ablation, 2015 - 2027
3.5 Global MRI-Guided Neurosurgical Ablation, by Region, 2015 - 2027
3.6 Global MRI-Guided Neurosurgical Ablation, by Type, 2015 - 2027
3.7 Global MRI-Guided Neurosurgical Ablation, by Application, 2015 - 2027

Chapter 4 MRI-Guided Neurosurgical Ablation Segment by Types (Product Category) 
4.1 Global MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Growth Rate (%) Comparison by Types (2015-2020) 
4.2 Global MRI-Guided Neurosurgical Ablation Revenue Market Share (%) by Types in 2019
4.3 RF Ablation Systems
4.4 Laser Ablation Systems
4.5 Focused Ultrasound Systems
4.6 Accessories

Chapter 5 Global MRI-Guided Neurosurgical Ablation Segment by Application 
5.1 Global MRI-Guided Neurosurgical Ablation Revenue (USD Million) Comparison by Application (2015-2027) 
5.2 Hospitals
5.3 Clinics2
5.4 Ambulatory Surgical Centers

Chapter 6 Global MRI-Guided Neurosurgical Ablation by Regions (2015-2027) 
6.1 Global MRI-Guided Neurosurgical Ablation Size and Growth Rate (%) Comparison by Regions (2015-2027) 
6.2 North America MRI-Guided Neurosurgical Ablation Status and Prospect (2015-2027) 
6.3 Europe MRI-Guided Neurosurgical Ablation Status and Prospect (2015-2027) 
6.4 Asia Pacific MRI-Guided Neurosurgical Ablation Status and Prospect (2015-2027) 
6.5 South America MRI-Guided Neurosurgical Ablation Status and Prospect (2015-2027) 
6.6 Middle East & Africa MRI-Guided Neurosurgical Ablation Status and Prospect (2015-2027) 
6.7 Global MRI-Guided Neurosurgical Ablation Size (2015-2027) 
            6.7.1 Global MRI-Guided Neurosurgical Ablation Revenue Status and Outlook (2015-2027) 
            
Chapter 7 PESTEL Analysis
7.1 Political Factors
7.2 Economic Factors
7.3 Social Factors
7.4 Technological Factors
7.5 Legal Factors
7.6 Environment Factors

Chapter 8 Global MRI-Guided Neurosurgical Ablation Competition by Manufacturers
8.1 Global MRI-Guided Neurosurgical Ablation Revenue and Share by Manufacturers (2015-2019) 

Chapter 9 Company (Top Players) Profiles and Key Data
9.1 Medtronic plc.
            9.1.1 Company Basic Information and Sales Area
            9.1.2 Business Segment/ Overview
            9.1.3 Investment in Research and Development
            9.1.4 MRI-Guided Neurosurgical Ablation Product Types Specification
            9.1.5 Key Developments
            9.1.6 Business Strategy
9.2 Insightec Lmt
            9.2.1 Company Basic Information and Sales Area
            9.2.2 Business Segment/ Overview
            9.2.3 Investment in Research and Development
            9.2.4 MRI-Guided Neurosurgical Ablation Product Types Specification
            9.2.5 Business Strategy
9.3 Boston Scientific Corporation
            9.3.1 Company Basic Information and Sales Area
            9.3.2 Business Segment/ Overview
            9.3.3 MRI-Guided Neurosurgical Ablation Product Types Specification
            9.3.4 Key Developments
            9.3.5 Business Strategy
9.4 Monteris Medical Inc.
            9.4.1 Company Basic Information and Sales Area. 
            9.4.2 Business Segment/ Overview
            9.4.3 MRI-Guided Neurosurgical Ablation Product Types Specification
            9.4.4 Business Strategy
9.5 AngioDynamics Inc.
            9.5.1 Company Basic Information and Sales Area. 
            9.5.2 Business Segment/ Overview
            9.5.3 MRI-Guided Neurosurgical Ablation Product Types Specification
            9.5.4 Business Strategy
9.6 MRI Interventions Inc.
            9.6.1 Company Basic Information and Sales Area
            9.6.2 Business Segment/ Overview
            9.6.3 MRI-Guided Neurosurgical Ablation Product Types Specification
            9.6.5 Key Developments
            9.6.6 Business Strategy
            
Chapter 10 Global MRI-Guided Neurosurgical Ablation Revenue by Regions (2015-2020) 
10.1 Global MRI-Guided Neurosurgical Ablation Revenue and Market Share (%) by Regions (2015-2020) 

Chapter 11 Global MRI-Guided Neurosurgical Ablation Revenue by Types
11.1 Global MRI-Guided Neurosurgical Ablation Revenue and Market Share (%) by Types (2015-2020) 

Chapter 12 Global MRI-Guided Neurosurgical Ablation Analysis by Application
12.1 Global MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Market Share (%) by Application (2015-2020) 
12.2 Global MRI-Guided Neurosurgical Ablation Revenue Growth Rate by Application (2015-2020) 

Chapter 13 North America MRI-Guided Neurosurgical Ablation Development Status and Outlook
13.1 North America MRI-Guided Neurosurgical Ablation Size (2015-2020) 
            13.1.1 North America MRI-Guided Neurosurgical Ablation Size by Type (USD Million) (2015-2020) 
13.2 North America MRI-Guided Neurosurgical Ablation Size (2015-2020) 
            13.2.1 North America MRI-GUIDED NEUROSURGICAL ABLATION Size by Application (USD Million) (2015-2020) 
13.3 U.S
            13.3.1 U.S. MRI-Guided Neurosurgical Ablation, by Type, 2015 - 2027
            13.3.2 U.S. MRI-Guided Neurosurgical Ablation, by Application, 2015 – 2027
13.4 Canada
            13.4.1 Canada MRI-Guided Neurosurgical Ablation, by Type, 2015 - 2027
            13.4.2 Canada MRI-Guided Neurosurgical Ablation, by Application, 2015 – 2027
13.5 Mexico
            13.5.1 Mexico MRI-Guided Neurosurgical Ablation, by Type, 2015 - 2027
            13.5.2 Mexico MRI-Guided Neurosurgical Ablation, by Application, 2015 – 2027
            
Chapter 14 Europe MRI-Guided Neurosurgical Ablation Development Status and Outlook
14.1 Europe MRI-Guided Neurosurgical Ablation Size (2015-2020) 
            14.1.1 Europe MRI-Guided Neurosurgical Ablation Size by Type (USD Million) (2015-2020) 
14.2 Europe MRI-Guided Neurosurgical Ablation Size (2015-2020) 
            14.2.1 Europe MRI-Guided Neurosurgical Ablation Size by Application (USD Million) (2015-2020) 
14.3 U.K.
            14.3.1 U.K. MRI-Guided Neurosurgical Ablation, by Type, 2015 - 2027
            14.3.2 U.K. MRI-Guided Neurosurgical Ablation, by Application, 2015 – 2027
14.4 Germany
            14.4.1 Germany MRI-Guided Neurosurgical Ablation, by Type, 2015 - 2027
            14.4.2 Germany MRI-Guided Neurosurgical Ablation, by Application, 2015 – 2027
14.5 France
            14.5.1 France MRI-Guided Neurosurgical Ablation, by Type, 2015 – 2027
            14.5.2 France MRI-Guided Neurosurgical Ablation, by Application, 2015 – 2027
14.6 Italy
            14.6.1 Italy MRI-Guided Neurosurgical Ablation, by Type, 2015 – 2027
            14.6.2 Italy MRI-Guided Neurosurgical Ablation, by Application, 2015 – 2027
14.7 Spain
            14.7.1 Spain MRI-Guided Neurosurgical Ablation, by Type, 2015 – 2027
            14.7.2 Spain MRI-Guided Neurosurgical Ablation, by Application, 2015 – 2027
14.8 Rest of Europe
            14.8.1 Rest of Europe MRI-Guided Neurosurgical Ablation, by Type, 2015 – 2027
            14.8.2 Rest of Europe MRI-Guided Neurosurgical Ablation, by Application, 2015 – 2027
            
Chapter 15 Asia Pacific MRI-Guided Neurosurgical Ablation Development Status and Outlook
15.1 Asia Pacific MRI-Guided Neurosurgical Ablation Size (2015-2020) 
            15.1.1 Asia Pacific MRI-Guided Neurosurgical Ablation Size by Type (USD Million) (2015-2020) 
15.2 Asia Pacific MRI-Guided Neurosurgical Ablation Size (2015-2020) 
            15.2.1 Asia Pacific MRI-GUIDED NEUROSURGICAL ABLATION Size by Application (USD Million) (2015-2020) 
15.3 China
            15.3.1 China MRI-Guided Neurosurgical Ablation, by Type, 2015 – 2027
            15.3.2 China MRI-Guided Neurosurgical Ablation, by Application, 2015 – 2027
15.4 Japan
            15.4.1 Japan MRI-Guided Neurosurgical Ablation, by Type, 2015 – 2027
            15.4.2 Japan MRI-Guided Neurosurgical Ablation, by Application, 2015 – 2027
15.5 India
            15.5.1 India MRI-Guided Neurosurgical Ablation, by Type, 2015 – 2027
            15.5.2 India MRI-Guided Neurosurgical Ablation, by Application, 2015 – 2027
15.6 Southeast Asia
            15.6.1 Southeast Asia MRI-Guided Neurosurgical Ablation, by Type, 2015 – 2027
            15.6.2 Southeast Asia MRI-Guided Neurosurgical Ablation, by Application, 2015 – 2027
            
Chapter 16 South America MRI-Guided Neurosurgical Ablation Development Status and Outlook
16.1 South America MRI-Guided Neurosurgical Ablation Size (2015-2020) 
            16.1.1 South America MRI-Guided Neurosurgical Ablation Size by Type (USD Million) (2015-2020) 
16.2 South America MRI-Guided Neurosurgical Ablation Size (2015-2020) 
            16.2.1 South America MRI-Guided Neurosurgical Ablation Size by Application (USD Million) (2015-2020) 
16.3 Brazil
            16.3.1 Brazil MRI-Guided Neurosurgical Ablation, by Type, 2015 – 2027
            16.3.2 Brazil MRI-Guided Neurosurgical Ablation, by Application, 2015 – 2027 
16.4 Argentina
            16.4.1 Argentina MRI-Guided Neurosurgical Ablation, by Type, 2015 – 2027
            16.4.2 Argentina MRI-Guided Neurosurgical Ablation, by Application, 2015 – 2027 
16.5 Colombia
            16.5.1 Colombia MRI-Guided Neurosurgical Ablation, by Type, 2015 – 2027
            16.5.2 Colombia MRI-Guided Neurosurgical Ablation, by Application, 2015 – 2027
16.6 Rest of South America
            16.6.1 Colombia MRI-Guided Neurosurgical Ablation, by Type, 2015 – 2027
            16.6.2 Colombia MRI-Guided Neurosurgical Ablation, by Application, 2015 – 2027
            
Chapter 17 Middle East & Africa MRI-Guided Neurosurgical Ablation Development Status and Outlook
17.1 Middle East & Africa MRI-Guided Neurosurgical Ablation Size (2015-2020) 
            17.1.1 Middle East & Africa MRI-Guided Neurosurgical Ablation Size by Type (USD Million) (2015-2020) 
17.2 Middle East & Africa MRI-Guided Neurosurgical Ablation Size (2015-2020) 
            17.2.1 Middle East & Africa MRI-Guided Neurosurgical Ablation Size by Application (2015-2020) 
17.3 UAE
            17.3.1 UAE MRI-Guided Neurosurgical Ablation, by Type, 2015 – 2027
            17.3.2 UAE MRI-Guided Neurosurgical Ablation, by Application, 2015 – 2027
17.4 South Africa
            17.4.1 South Africa MRI-Guided Neurosurgical Ablation, by Type, 2015 – 2027
            17.4.2 South Africa MRI-Guided Neurosurgical Ablation, by Application, 2015 – 2027
17.5 Egypt
            17.5.1 Egypt MRI-Guided Neurosurgical Ablation, by Type, 2015 – 2027
            17.5.2 Egypt MRI-Guided Neurosurgical Ablation, by Application, 2015 – 2027
17.6 Rest of MEA
            17.6.1 Rest of MEA MRI-Guided Neurosurgical Ablation, by Type, 2015 – 2027
            17.6.2 Rest of MEA MRI-Guided Neurosurgical Ablation, by Application, 2015 – 2027
            
Chapter 18 MRI-Guided Neurosurgical Ablation Manufacturing Cost Analysis
18.1 Proportion of Manufacturing Cost Structure
            18.1.1 Raw Materials
            18.1.2 Labor Cost
            18.1.3 USA Labor Cost Analysis
            18.1.4 EU Labor Costs Analysis
            18.1.5 China Labor Costs Analysis
            18.1.6 Manufacturing Expenses
            
Chapter 19 Marketing Strategy Analysis, Distributors/ Traders
19.1 Marketing Channel
            19.1.1 Direct Marketing
            19.1.2 Indirect Marketing
            19.1.3 Marketing Channel Development Trend
19.2 Market Positioning
            19.2.1 Pricing Strategy
            
Chapter 20 Global MRI-Guided Neurosurgical Ablation Forecast (2020-2027) 
20.1 Global MRI-Guided Neurosurgical Ablation Revenue Forecast (2020-2027) 
            20.1.1 Global MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Growth Rate (%) Forecast (2020-2027) 
20.2 Global MRI-Guided Neurosurgical Ablation Revenue (USD Million) Forecast by Regions (2020-2027) 
            20.2.1 North America MRI-Guided Neurosurgical Ablation Revenue (USD Million) Forecast (2020-2027) 
            20.2.2 Europe MRI-Guided Neurosurgical Ablation Revenue (USD Million) Forecast (2020-2027) 
            20.2.3 Asia Pacific MRI-Guided Neurosurgical Ablation and Revenue (USD Million) Forecast (2020-2027) 
            20.2.4 South America MRI-Guided Neurosurgical Ablation and Revenue (USD Million) Forecast (2020-2027) 
            20.2.5 Middle East & Africa MRI-Guided Neurosurgical Ablation and Revenue (USD Million) Forecast (2020-2027) 
20.3 Global MRI-Guided Neurosurgical Ablation Revenue Forecast by Type (2020-2027) 
20.4 Global MRI-Guided Neurosurgical Ablation Revenue (USD Million) Forecast by Application (2020-2027) 

Chapter 21 North America MRI-Guided Neurosurgical Ablation Development Status and Outlook
21.1 North America MRI-Guided Neurosurgical Ablation Size (2020-2027) 
            21.1.1 North America MRI-Guided Neurosurgical Ablation Size by Type (USD Million) (2020-2027) 
21.2 North America MRI-Guided Neurosurgical Ablation Size (2020-2027) 
            21.2.1 North America MRI-Guided Neurosurgical Ablation Size by Application (USD Million) (2020-2027) 
21.3 U.S.
            21.3.1 U.S. MRI-Guided Neurosurgical Ablation, by Type, 2020 – 2027
            21.3.2 U.S. MRI-Guided Neurosurgical Ablation, by Application, 2020 – 2027
21.4 Canada
            21.4.1 Canada MRI-Guided Neurosurgical Ablation, by Type, 2020 – 2027
            21.4.2 Canada MRI-Guided Neurosurgical Ablation, by Application, 2020 – 2027
21.5 Mexico
            21.5.1 Mexico MRI-Guided Neurosurgical Ablation, by Type, 2020 – 2027
            21.5.2 Mexico MRI-Guided Neurosurgical Ablation, by Application, 2020 – 2027
            
Chapter 22 Europe MRI-Guided Neurosurgical Ablation Development Status and Outlook
22.1 Europe MRI-Guided Neurosurgical Ablation Size (2020-2027) 
            22.1.1 Europe MRI-Guided Neurosurgical Ablation Size by Type (USD Million) (2020-2027) 
22.2 Europe MRI-Guided Neurosurgical Ablation Size (2020-2027) 
            22.2.1 Europe MRI-Guided Neurosurgical Ablation Size by Application (USD Million) (2020-2027) 
22.3 U.K.
            22.3.1 U.K. MRI-Guided Neurosurgical Ablation, by Type, 2020 – 2027
            22.3.2 U.K. MRI-Guided Neurosurgical Ablation, by Application, 2020 – 2027
22.4 Germany
            22.4.1 Germany MRI-Guided Neurosurgical Ablation, by Type, 2020 – 2027
            22.4.2 Germany MRI-Guided Neurosurgical Ablation, by Application, 2020 – 2027
22.5 France
            22.5.1 France MRI-Guided Neurosurgical Ablation, by Type, 2020 – 2027
            22.5.2 France MRI-Guided Neurosurgical Ablation, by Application, 2020 – 2027
22.6 Italy
            22.6.1 France MRI-Guided Neurosurgical Ablation, by Type, 2020 – 2027
            22.6.2 France MRI-Guided Neurosurgical Ablation, by Application, 2020 – 2027
22.7 Spain
            22.7.1 France MRI-Guided Neurosurgical Ablation, by Type, 2020 – 2027
            22.7.2 France MRI-Guided Neurosurgical Ablation, by Application, 2020 – 2027
22.8 Rest of Europe
            22.8.1 France MRI-Guided Neurosurgical Ablation, by Type, 2020 – 2027
            22.8.2 France MRI-Guided Neurosurgical Ablation, by Application, 2020 – 2027
            
Chapter 23 Asia Pacific MRI-Guided Neurosurgical Ablation Development Status and Outlook
23.1 Asia Pacific MRI-Guided Neurosurgical Ablation Size (2020-2027) 
            23.1.1 Asia Pacific MRI-Guided Neurosurgical Ablation Size by Type (USD Million) (2020-2027) 
23.2 Asia Pacific MRI-Guided Neurosurgical Ablation Size (2020-2027) 
            23.2.1 Asia Pacific MRI-Guided Neurosurgical Ablation Size by Application (USD Million) (2020-2027) 
23.3 China
            23.3.1 China MRI-Guided Neurosurgical Ablation, by Type, 2020 – 2027
            23.3.2 China MRI-Guided Neurosurgical Ablation, by Application, 2020 – 2027
23.4 Japan
            23.4.1 Japan MRI-Guided Neurosurgical Ablation, by Type, 2020 – 2027
            23.4.2 Japan MRI-Guided Neurosurgical Ablation, by Application, 2020 – 2027
23.5 India
            23.5.1 India MRI-Guided Neurosurgical Ablation, by Type, 2020 – 2027
            23.5.2 India MRI-Guided Neurosurgical Ablation, by Application, 2020 – 2027
23.6 Southeast Asia
            23.6.1 Southeast Asia MRI-Guided Neurosurgical Ablation, by Type, 2020 – 2027
            23.6.2 Southeast Asia MRI-Guided Neurosurgical Ablation, by Application, 2020 – 2027
            
Chapter 24 South America MRI-Guided Neurosurgical Ablation Development Status and Outlook
24.1 South America MRI-Guided Neurosurgical Ablation Size (2020-2027) 
            24.1.1 South America MRI-Guided Neurosurgical Ablation Size by Type (USD Million) (2020-2027) 
24.2 South America MRI-Guided Neurosurgical Ablation Size (2020-2027) 
            24.2.1 South America MRI-Guided Neurosurgical Ablation Size by Application (USD Million) (2020-2027) 
24.3 Brazil
            24.3.1 Brazil MRI-Guided Neurosurgical Ablation, by Type, 2020 – 2027
            24.3.2 Brazil MRI-Guided Neurosurgical Ablation, by Application, 2020 – 2027 
24.4 Argentina
            24.4.1 Argentina MRI-Guided Neurosurgical Ablation, by Type, 2020 – 2027
            24.4.2 Argentina MRI-Guided Neurosurgical Ablation, by Application, 2020 – 2027 
24.5 Colombia
            24.5.1 Colombia MRI-Guided Neurosurgical Ablation, by Type, 2020 – 2027
            24.5.2 Colombia MRI-Guided Neurosurgical Ablation, by Application, 2020 – 2027
24.6 Rest of South America
            24.6.1 Colombia MRI-Guided Neurosurgical Ablation, by Type, 2020 – 2027
            24.6.2 Colombia MRI-Guided Neurosurgical Ablation, by Application, 2020 – 2027
            
Chapter 25 Middle East & Africa MRI-Guided Neurosurgical Ablation Development Status and Outlook
25.1 Middle East & Africa MRI-Guided Neurosurgical Ablation Size (2020-2027) 
            25.1.1 Middle East & Africa MRI-Guided Neurosurgical Ablation Size by Type (USD Million) (2020-2027) 
25.2 Middle East & Africa MRI-Guided Neurosurgical Ablation Size (2020-2027) 
            25.2.1 Middle East & Africa MRI-Guided Neurosurgical Ablation Size by Application (USD Million) (2020-2027) 
25.3 UAE
            25.3.1 UAE MRI-Guided Neurosurgical Ablation, by Type, 2020 – 2027
            25.3.2 UAE MRI-Guided Neurosurgical Ablation, by Application, 2020 – 2027
25.4 South Africa
            25.4.1 South Africa MRI-Guided Neurosurgical Ablation, by Type, 2020 – 2027
            25.4.2 South Africa MRI-Guided Neurosurgical Ablation, by Application, 2020 – 2027
25.5 Egypt
            25.5.1 Egypt MRI-Guided Neurosurgical Ablation, by Type, 2020 – 2027
            25.5.2 Egypt MRI-Guided Neurosurgical Ablation, by Application, 2020 – 2027
25.6 Rest of MEA
            25.6.1 Rest of MEA MRI-Guided Neurosurgical Ablation, by Type, 2020 – 2027
            25.6.2 Rest of MEA MRI-Guided Neurosurgical Ablation, by Application, 2020 – 2027
            
Chapter 26 Research Findings and Conclusion




 
 
 
 

No Methodology

Global MRI-Guided Neurosurgical Ablation Market Trends:
The global MRI-guided neurosurgical ablation is estimated to be worth USD 493.40 million in 2019 and is projected to reach USD 853.58 million by 2027, at a CAGR of 7.3% from 2020 to 2027.

Neurosurgical ablation is the brain surgery, which is also known as brain lesioning. This is done by various methods of brain tissue to treat neurological or psychological disorders. The MRI-guided ablation method minimizes incisions as well as it allows surgeons to cosmetically hide scars. The MRI-guided neurosurgical ablation is also used in the other End-Users like brain tumors and benign brain tumors. MRI-guided neurosurgical helps patients to recover faster as compared to the traditional method of treatment.

Increasing occurrence of brain tumors and other nervous system associated disorders is one of the major factors that is driving the growth of the global MRI-guided neurosurgical ablation market. Along with this, growing awareness among people regarding the treatment and diagnosis is another factor that is also driving the growth of the global MRI-guided neurosurgical ablation market. Thus, patients prefer less invasive surgeries because they reduce the recovery time and surgeons also uses various tools to reduce trauma to body tissue during surgeries is one of the major factor that will drive the growth of the global MRI-guided neurosurgical ablation market in the forecast period. Along with this, increasing number of cases of neurological disorders in developed and developing countries is anticipated to boost the growth of the global MRI-guided neurosurgical ablation market in the forecast period. However, lack of skilled and trained professional that are required for surgery is one of the major factor that is hampering the growth of the global MRI-guided neurosurgical ablation market. Along with this, high cost associated with the MRI-guided neurosurgical ablation is another factor that is also restraining the growth of the global MRI-guided neurosurgical ablation market.

Global MRI-Guided Neurosurgical Ablation Market, By Type:
On the basis of type, accessories segment accounted for largest share of total revenue generated, because there are various accessories that are used while performing surgeries like curettes, rongeurs and dissectors, along with this, the accessories are also designed to help neurosurgeons in the diagnosis and restoration of the central nervous system.

Global MRI-Guided Neurosurgical Ablation, By Application:
The demand of Global MRI-Guided Neurosurgical Ablation Market is highest from hospital segment, because almost all the neurosurgeries are performed in hospitals, hospitals are well equipped with technologically advanced products and hospitals has skilled neurosurgeons to perform complicated neurosurgical procedures.

Global MRI-Guided Neurosurgical Ablation market, By Region:
Report covers the region wise analysis, global MRI-guided neurosurgical ablation can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Among all, North America held the largest share in the market because of the presence of well-established healthcare facilities, increasing prevalence of brain cancers as well as malignant tumors in the brain and presence of major key players in the U.S. region. Asia Pacific is also having maximum share in the MRI-guided neurosurgical ablation market, which is followed by the Europe region.

Major Market Players:
The research study includes profiles of leading companies operating in the global MRI-guided neurosurgical ablation market. Key players profiled in the report include: Monteris Medical Inc, Medtronic plc, Insightec Lmt, AngioDynamics Inc, MRI Intervention Inc. and Boston Scientific Corporation.

Global MRI-Guided Neurosurgical Ablation Market Report Scope:
Report Parameters Details of Parameter
Market Size 2015-2027
Based Year 2019
Forecast Period Covered 2020-2027
Units for value USD (Million)
Covered Segments Product Type, Application, Geographic Regions
Product Type RF Ablation Systems, Laser Ablation Systems, Focused Ultrasound Systems, Accessories
Applications Hospitals, Clinics, and Ambulatory Surgical Centers
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Covered Monteris Medical Inc, Medtronic plc, Insightec Lmt, AngioDynamics Inc, MRI Intervention Inc. and Boston Scientific Corporation

The report analyzes all the factors which are impacting on the market and on that basis describes the drivers, restraints, and opportunities for the growth of the global MRI-guided neurosurgical ablation market. Similarly, report provides the all the segmentations along with the qualitative analysis.

Global MRI-Guided Neurosurgical Ablation Market: Product analysis
  • RF Ablation Systems
  • Laser Ablation Systems
  • Focused Ultrasound Systems
  • Accessories
Global MRI-Guided Neurosurgical Ablation Market: Application analysis
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
Market, by regions:
In addition, MRI-guided neurosurgical ablation report sorted and categorized the information and data according to the major geographical regions which are expected to impact on the industry in forecast period. Following are the regions we covered in this report:
  • North America (U.S., Canada, Mexico)
  • Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS)
  • Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)
  • Latin America (Brazil, Rest of L.A.)
  • Middle East and Africa (Turkey, GCC, Rest of Middle East)
 
 
 

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase